Skip to main content
Homepage
Full 18-step deep-dive · ~20–30 min · a member feature.
AGING Analysis Report
Aug 3, 2026
20 days ago · 100% complete
UNVERIFIED BASIS Generated before the data-freshness fixes of Aug 14, 2026 — treat as indicative.
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for Tat Technologies Ltd. (TATT) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Our current read (analysis of 2026-08-23): Designation Low · Gem Score -29 (−100…+100 Quality+Value blend) · Quality 20 · Value -69 · Sentiment 51 (timing only, not weighted) · Composite fair value $13.58 vs $38.75 at analysis

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysisthe core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at delvantic.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

Tat Technologies Ltd.

TATT NASDAQ
Industrials · Aerospace & Defense
Charlotte, NC 28269, United States tat-technologies.com Updated Aug 3, 12:04pm
Price
$38.75
Market Cap
$505.0M
Employees
659
Beta
0.98
Avg Volume
210,923
CEO
Mr. Igal Zamir

TAT Technologies Ltd. is a leading provider of products and services to the commercial and military aerospace and ground defense industries. The company specializes in original equipment manufacturing of heat transfer solutions and aviation accessories, including heat exchangers, precoolers, oil coolers, environmental control systems, and power electronics cooling systems essential for aircraft machinery, electronics, and defense platforms. It also offers maintenance, repair, and overhaul services for aviation components such as auxiliary power units and landing gear, as well as specialized overhaul and coating for jet engine components like turbine vanes, blades, and afterburner flaps. Operating through key segments focused on thermal management, power and actuation, and MRO services, TAT Technologies supports airlines, OEMs, air forces, and defense agencies with innovative solutions that enhance operational efficiency and reliability. Founded in 1969 and headquartered in Netanya, Israel, the company maintains a global presence with state-of-the-art facilities to deliver precise, high-standard aerospace technologies.

Runs with full report Generated: Aug 3, 2026 12:20pm
Price Overview
Price at report time
$38.80
as of Aug 3, 12:46pm (20d ago)
Change · Aug 3
-0.10 (-0.26%)
Day Range
$38.38 – $39.75
52-Week Range
$30.36 – $64.50
50-Day MA
$42.90
200-Day MA
$44.06
Volume
27,116.00
Right now · live
Log in to get the live feed
Members see the real-time price and the move since this report (over 20d).
Share Structure
Outstanding 12,983,137.00
Float 12,961,715.00
Free Float 99.8%
High free float — 99.8% of shares trade freely, ~0.2% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Aug 3, 2026 12:46pm (20d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Aug 3, 2026 12:04pm (20d ago)
Why there are no quarterly figures for Tat Technologies Ltd.

Tat Technologies Ltd. is a foreign private issuer — it reports to the U.S. SEC once a year (on Form 20-F or 40-F) rather than filing the quarterly statements (10-Q) that U.S.-domiciled companies must submit. Our financial statements are read directly from SEC filings, so for this company only annual figures exist at the source.

This is a property of how the company files, not missing or broken data — its filing history shows 13 annual reports, the latest filed 2026-03-18, and no quarterly filings . The company may still publish quarterly results on its own investor-relations site.

Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
TD Twelve Data statement HEX SEC filing
Industry comparison last run: Aug 3, 2026 12:19pm
P/E Ratio (Price per dollar of earnings)
HEX
Stock Price / EPS (Diluted)
28.28
Stock Price: $38.75
EPS (Diluted): 1.37
P/B Ratio (Price vs net asset value)
HEX
Stock Price / Book Value Per Share
2.70
Stock Price: $38.75
Total Equity: $176.39M
Shares: 12,283,312
EV/EBITDA (Total value vs operating profit)
HEX
Enterprise Value / EBITDA
19.47
Market Cap: $505.04M
Total Debt: $11.71M
Cash: $51.26M
EBITDA: $23.91M
Enterprise Value (Takeover price (cap + debt - cash))
HEX
Market Cap + Total Debt - Cash
$465.5M
Market Cap: $505.04M
Total Debt: $11.71M
Cash: $51.26M
Gross Margin (Revenue left after direct costs)
HEX
Gross Profit / Revenue
24.8%
Gross Profit: $44.10M
Revenue: $178.02M
Operating Margin (Revenue left after all operations)
HEX
Operating Income / Revenue
10.6%
Operating Income: $18.81M
Revenue: $178.02M
Net Margin (Revenue left as actual profit)
HEX
Net Income / Revenue
9.4%
Net Income: $16.82M
Revenue: $178.02M
ROE (Profit from shareholder equity)
HEX
Net Income / Total Equity
9.5%
Net Income: $16.82M
Total Equity: $176.39M
ROIC (Profit from all invested capital)
HEX
NOPAT / Invested Capital
12.1%
Operating Income: $18.81M
Tax Rate: 12.3%
Equity: $176.39M
Total Debt: $11.71M
Cash: $51.26M
Current Ratio (Can it pay short-term bills)
HEX
Current Assets / Current Liabilities
4.89
Current Assets: $166.30M
Current Liabilities: $33.98M
Debt/Equity (Leverage — debt vs equity)
HEX
Total Debt / Total Equity
0.07
Short-Term Debt: $2.23M
Long-Term Debt: $9.49M
Total Debt: $11.71M
Total Equity: $176.39M
Rev/Share (Top-line per share)
HEX
Revenue / Shares Outstanding
$14.49
Revenue: $178.02M
Shares: 12,283,312
Book Value/Share (Net assets per share)
HEX
(Total Assets - Total Liabilities) / Shares
$14.36
Total Equity: $176.39M
Shares: 12,283,312
FCF/Share (Real cash generated per share)
HEX
(Operating Cash Flow + CapEx) / Shares
$0.33
Operating CF: $14.97M
CapEx: -$10.95M
Shares: 12,283,312
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
TD
Last Annual Dividend / Stock Price
Last Dividend: $0.00
Stock Price: $38.75
Payout Ratio (Earnings paid out as dividends)
HEX
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $16.82M
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Aug 3, 2026 12:19pm
Compares TATT against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Income Statement (Annual)
Last updated: Aug 3, 2026 12:04pm (20d ago)
Metric 2021 2022 2023 2024 2025
Revenue $78.0M $84.6M $113.8M $152.1M $178.0M
Cost of Revenue $66.7M $68.6M $91.3M $119.1M $133.9M
Gross Profit $11.3M $15.9M $22.5M $33.0M $44.1M
Operating Expenses $15.3M $17.7M $16.4M $20.5M $25.3M
Operating Income -$4.0M -$1.8M $6.1M $12.5M $18.8M
Net Income -$3.6M -$1.6M $4.7M $11.2M $16.8M
EBITDA $846,000 $1.9M $10.8M $18.0M $23.9M
EPS $-0.40 $-0.18 $0.52 $1.08 $1.39
EPS (Diluted) $-0.40 $-0.18 $0.51 $1.00 $1.37
Balance Sheet (Annual)
Last updated: Aug 3, 2026 12:04pm (20d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $12.9M $7.7M $16.0M $7.1M $51.3M
Total Current Assets $72.0M $75.2M $94.3M $113.2M $166.3M
Total Assets $110.8M $126.7M $145.6M $163.4M $226.7M
Current Liabilities $24.6M $29.0M $39.3M $38.1M $34.0M
Long-Term Debt $6.0M $19.4M $12.9M $10.9M $9.5M
Total Liabilities $34.0M $51.1M $54.9M $51.4M $50.3M
Total Equity $76.8M $75.6M $90.7M $112.0M $176.4M
Retained Earnings $10.2M $8.6M $13.3M $24.4M $41.3M
Cash Flow (Annual)
Last updated: Aug 3, 2026 12:04pm (20d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$4.9M $2.3M -$5.8M $15.0M
Capital Expenditure -$16.2M -$16.2M -$5.1M -$5.1M -$11.0M
Free Cash Flow -$21.1M -$2.8M -$10.9M $4.0M
Acquisitions (net)
Net Debt Issued / (Repaid) $3.0M $15.6M $-989,000 -$2.0M -$2.1M
Dividends Paid
Stock Buybacks
Net Change in Cash -$11.1M -$5.2M $8.9M -$9.5M $44.1M
Growth Trends (YoY %)
Last updated: Aug 3, 2026 12:04pm (20d ago)
Metric 2022 2023 2024 2025
Revenue Growth +8.4% +34.6% +33.7% +17.0%
Gross Profit Growth +41.3% +41.1% +46.9% +33.6%
Operating Income Growth +56.0% +442.3% +105.8% +50.5%
Net Income Growth +56.1% +399.1% +139.0% +50.6%
EBITDA Growth +128.3% +458.5% +66.5% +33.2%
Dividend History (Last 20)
Last updated: Aug 3, 2026 12:04pm (20d ago)
Date Dividend Declaration Record Payment
2017-06-05 $0.34
2016-07-25 $0.34
2014-04-21 $0.23
2012-05-01 $0.28
2009-11-19 $0.30
2009-03-24 $0.55
2007-10-12 $0.40
2006-05-12 $0.20
2005-10-18 $0.18
2004-10-14 $1.18
2003-06-27 $0.25
2003-01-02 $0.45
0Company Classification 1Industry Landscape 2Company Momentum 3Forward Projection 4aDCF Valuation 4bEarnings Power Value 4cAnchored PE 4dReverse DCF 4eRevenue-Based DCF 4fAnchored P/S 4gScenario Analysis 4hDividend Discount Model 4iBook Value Analysis 4jInsider Activity 4fCash Flow Quality 4gDebt Maturity Risk 4hMacro Environment 4iSector Intelligence 4jRevenue Confidence 4kSensitivity Analysis 4lSector Demand Cycle 5AI Investigation 5bThesis Evaluation 6Valuation Synthesis
computed not applicable not yet run 14 computed · 6 not applicable · 4 not yet run
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for TATT — it's generated by the pipeline (market-narrative step).
Claude Reading
Independent analyst synthesis · claude-opus-4-7 · generated 2026-08-03 12:44:54
Verdict Modestly overvalued at $38.75 — fair value $28-32 on normalized earnings; synthesis's $14 target is wrong, but so is the aerospace-supercycle bull case. Wait for a pullback to low-$30s or cash conversion proof.

The raw numbers tell a coherent operational story that the synthesis engine is mispricing. Revenue went $78M→$85M→$114M→$152M→$178M over five years — that's a 23% CAGR, and 2025's 17% YoY on a larger base is deceleration but hardly stall-out. More importantly, gross margin walked from 14.5% (2021) to 24.8% (2025), and operating margin flipped from -5.1% to +10.6%. This is textbook operating leverage in a recovering aerospace MRO cycle, not accounting fiction. Net income of $16.8M on $178M revenue is real; ROIC of 12.1% on a nearly debt-free balance sheet ($11.7M debt vs $51.3M cash, current ratio 4.9x) is respectable for a small-cap industrial. The synthesis verdict claiming $13.58 fair value — a 65% discount — implies the market is hallucinating the entire earnings recovery, which is not what the P&L shows.

That said, the "Poor Cash Flow Quality" flag deserves real weight and the prior models undersell why. OpCF of $15.0M against NI of $16.8M is fine on the surface, but FCF of only $4.0M after $11.0M capex — on a business supposedly benefiting from a multi-year backlog — is thin. The gap between 90% earnings CAGR and single-digit FCF is likely working capital build (inventory + receivables for MRO growth), which is normal but means the "earnings" you're paying 28x for aren't yet cash. At $38.75 and ~$0.51B market cap, EV/FCF is roughly 115x — indefensible unless capex normalizes hard or working capital unwinds. The insider pattern is also worse than "Neutral": six consecutive same-day option-exercise-and-sell transactions in mid-2026 is not accumulation, it's mechanical monetization. Not a red flag, but not confidence-inspiring either.

Where I dissent from the models: the $14 DCF fair value is almost certainly using stale or overly punitive assumptions — probably anchoring on 2022-2023 profitability or applying a mature-industrial multiple to a business mid-transition. A more honest frame: at 2025 run-rate earnings of $16.8M growing 30-50% and normalizing to maybe 15-20% forward, a 20-22x forward P/E gets you to $25-30 fair value, not $14. The Market Forces "value trap masquerading as growth" call is lazy — TAT isn't reporting phantom revenue; it's reporting real revenue with a working-capital drag typical of inventory-heavy MRO scale-up. Where I dissent from the bulls: the fallen-angel narrative correctly notes there's no moat evidence, and aerospace MRO cyclicality is real. If commercial aerospace normalizes and defense budgets flatten post-2026, this same operating leverage runs in reverse — 25% gross margins could compress back to 18-20% fast, and then you're paying 28x peak earnings.

A careful contrarian would ask: why does a supposedly "critical single-source supplier" earn only 24.8% gross margins and 9.5% ROE? Real aerospace moats (HEI, TDG) run 35%+ gross and 20%+ ROIC. TAT's returns say "competent subcontractor riding a cycle," not "essential niche monopolist." The narrative layer is right that intensity is strong and durability is fragile — the stock already fell 40% from highs, meaning some air is out but not all. Fair value in my read: $28-32, using 18-20x normalized $1.60-1.80 EPS with modest growth. Current $38.75 embeds ~25% cycle-peak premium. Not a $14 stock, not a $50 stock. The models are directionally right (overvalued) but wildly wrong on magnitude — a $14 target would require the entire earnings base to be fictitious, and it isn't.

GPT Reading
Independent reading · gpt-5.4 · generated 2026-08-03 12:45:10
Verdict Slightly overvalued at $38.75 — the turnaround is real, but the stock already prices sustained double-digit growth and better cash conversion; fair value looks closer to $28-$32.

What jumps out is that TAT is not a stagnant “mature earner” at all; it is a very small aerospace supplier that has already gone through a sharp earnings inflection. Revenue has risen from $78.0M in 2021 to $178.0M in 2025, a 2.3x increase in four years, while operating income moved from a $4.0M loss to $18.8M and net income from a $3.6M loss to $16.8M. That is not accounting noise alone. Gross margin expanded from 14.5% to 24.8%, operating margin from -5.1% to 10.6%, and ROIC reached 12.1%. This looks like a business benefiting from real volume recovery and mix improvement in commercial aerospace and defense MRO, not just a spreadsheet artifact. The balance sheet reinforces that read: $51.3M of cash against just $11.7M of debt on a $510M market cap gives it meaningful net cash and limits existential downside.

The more important question is not whether the business has improved, but whether the stock already discounts too much of that improvement. At $38.75, investors are paying about 28.3x earnings, 2.67x sales, and 19.5x EV/EBITDA for a company that generated only $4.0M of free cash flow in 2025. Even adjusting for growth, that is a rich multiple set for a niche industrial with sub-$200M revenue and clear cyclicality. The sticking point is capex and cash conversion: operating cash flow was $15.0M, respectable versus $16.8M of net income, but capex of $11.0M consumed most of it. If that capex is temporary growth investment, the earnings power is understated on an FCF basis; if it is structural to sustain the business, then the market is capitalizing earnings far too generously. My read is that the equity is pricing in another leg of margin expansion from 10.6% operating margin toward something like 12-14%, plus continued double-digit revenue growth. That can happen, but at this valuation there is not much room for normal aerospace lumpiness.

I therefore land moderately bearish on valuation, but not for the simplistic reason that some model says fair value is $14. That kind of deep-discount DCF conclusion seems disconnected from the actual operating trajectory. A company that has compounded revenue 25% annually since 2021, restored profitability, and built a net-cash balance sheet deserves a premium to sleepy industrial peers. The issue is that the current price seems to capitalize a best-case continuation. On 2025 numbers, the enterprise value is roughly $470M after netting cash, which is about 25x operating income for a business with 24.8% gross margins and modest free cash generation. For me, fair value is not collapse territory; it is more like the high $20s to low $30s unless cash flow catches up meaningfully.

The best argument against my caution is straightforward: these numbers may still under-earn the cycle. If 2025’s $11.0M capex was mostly expansionary, then normalized free cash flow could be closer to operating cash flow than reported FCF, and the stock is cheaper than it appears. Likewise, if commercial aerospace aftermarket demand and defense programs keep driving utilization, a business now at 10.6% operating margin could plausibly reach low-teens margins on $200M+ revenue. In that scenario, net income could move from $16.8M toward $22M-$25M without heroic assumptions, bringing the current share price down into the low-20s P/E on forward earnings. Given the clean balance sheet, a strategic premium is also not absurd for a niche supplier with hard-to-replace certifications and customer relationships. That is why I do not buy the extreme bear case.

What would change my mind is evidence that TAT can convert this accounting improvement into durable cash and sustain growth without stretching the capital base. If the next annual period shows revenue above $195M, operating margin holding above 10.5%, and free cash flow stepping up into at least the $10M-$12M range, I would be more constructive even around the current price because the cash conversion objection would weaken sharply. Conversely, if revenue growth slips to single digits, margins retrace below 9%, or capex stays elevated without a matching rise in operating cash flow, then the stock should de-rate hard because the current multiple only works if 2025 was a waypoint, not a peak.

Grok Reading
Independent reading · grok-4.5 · generated 2026-08-03 12:46:00
Verdict Overvalued at $38.75 — real aerospace turnaround and clean BS, but 28x earnings on only $4M FCF overpays; fair closer to $22-26

The numbers tell a genuine multi-year operational turnaround, not an accounting fiction. Revenue scaled from $78M in 2021 to $178M in 2025 (25% CAGR), while net income swung from a $3.6M loss to $16.8M profit; gross margin lifted from ~14.5% to 24.8% and operating margin reached 10.6%. That is real volume recovery plus mix and operating leverage in aerospace thermal management and MRO. The balance sheet is a fortress—$51.3M cash, only $11.7M debt, equity $176M, current ratio 4.9, D/E 0.07—so there is no solvency or dilution overhang. Recent prints still show 17% revenue growth and 51% earnings growth. ROIC at 12% and ROE at 9.5% are respectable for a small hardware manufacturer exiting a trough. This is not a mature earner; it is a cyclical recovery that has executed.

Cash tells a harsher story. Operating cash flow of $15M looks adequate against $16.8M net income, yet $11M of capex leaves only $4M of free cash flow—roughly 24% conversion. At a $510M market cap and $38.75 share price the stock trades at 28x trailing earnings, 2.7x sales and 19.5x EV/EBITDA. Those multiples price in continued mid-teens growth and further margin expansion for years; they do not leave room for the cash conversion gap or for any slowdown in commercial aerospace rates. The prior models’ ~$14 DCF is too punitive given the growth trajectory and net-cash position, but $38.75 still embeds far more durability than a mid-teens-margin, cyclical supplier with modest ROIC has earned. I read the business as improved and the stock as stretched.

The strongest opposing case is that TAT sits in constrained niches with high switching costs and multi-year platform exposure, so the growth is structural rather than purely cyclical. Defense budgets remain elevated, OEM production is still normalizing, and a company that has just doubled revenue while expanding margins can justify 20–25x earnings if ROIC keeps climbing and growth capex today converts into higher FCF tomorrow. The stock is already off ~40% from its highs, so some re-rating risk is already realized; bulls can argue 28x on 50% earnings growth with a clean balance sheet is tolerable for a niche aerospace name until earnings catch the multiple. I discount that view because current 10.6% operating margins and 12% ROIC do not yet prove fortress economics, FCF remains thin, and narrative durability is explicitly fragile—any backlog or margin miss will compress the multiple hard.

Two clean quarters of FCF conversion above 70% of net income while holding 15%+ revenue growth, or disclosed multi-year backlog coverage well above 1.5x revenue with accretive mix, would force me to reassess the premium as partially earned. A sustained break below $25 without fundamental deterioration would flip the risk/reward enough to turn constructive.

Big-3 Panel — where each AI stands
Each AI above independently stated a direction (undervalued, fairly valued, or overvalued) and how strongly it believes it (conviction, 0–5). We combine those into a Bull-Bear Index on a 0–10 scale: 5 is neutral, 10 is maximum bullish (undervalued at full conviction), 0 is maximum bearish. We compute the score ourselves with the same arithmetic for every seat — the models never grade their own bullishness — so the three are directly comparable. Δ shows how far each seat sits from the panel average of 1.7; a large Δ marks the dissenting voice, usually the one worth reading.
Claude claude-opus-4-7 2.0
overvalued · conviction 3/5 · Δ +0.3 vs panel · self: 4.0
GPT gpt-5.4 2.0
overvalued · conviction 3/5 · Δ +0.3 vs panel · self: 4.0
Grok grok-4.5 1.0
overvalued · conviction 4/5 · Δ -0.7 vs panel · self: 3.0
Advanced Analysis Forensic deep-dive · separate lenses
Separate reads — Company Quality (is it a great business?), Valuation (is it mispriced?), and General Sentiment (how macro + narrative are pushing it), kept deliberately apart · 2026-08-03 13:54:53
Delvantic - Cairn AI
Quality - wait for a dip 7/10
Real aerospace MRO turnaround, but the tape has already paid for it - great business, wrong price.
The cruxWhether 2025's first year of positive FCF ($4M on $16.8M NI) proves to be a sustained cash-conversion inflection or a one-off; without that, $39 has no anchor beneath it.
Forensic checks Derived mechanically from TATT's filed financials — not from the AI lenses
Liquidity & RunwaySelf-Funding
DilutionHeavy Dilution
Earnings QualityGood Earnings Quality
The four lensesswitch a tab for its full read — score + evidence
Company Quality
+20
Solid
edge √Σ 106 · risk √Σ 85 · conf 7/10

Tat Technologies has produced a striking multi-year operating inflection: revenue compounded from $78.0M (2021) to $178.0M (2025), gross margin widened from 14.5% to 24.8%, and operating margin swung from -5.2% to +10.6%. Net income moved from -$3.6M to +$16.8M over the same span, and the balance sheet is clean with $51.3M liquid cash, $39.5M net cash, and an Altman Z of 8.03. Beneish M at -2.24 and OCF/NI at 0.99x in 2025 support that the reported earnings are real rather than accrual-driven (accruals 3.9% of assets).

Strengths 3
m78
Genuine margin and profit inflection
Gross margin expanded 1030bps (14.5% to 24.8%) and operating margin swung from -5.2% to +10.6% over four years while revenue more than doubled - evidence of real operating leverage in the aerospace MRO niche.
m55
Fortress-adjacent balance sheet
$39.5M net cash, Altman Z of 8.03, and no reliance on external capital give ample survival cushion for a $178M-revenue industrial.
m45
Clean mechanical earnings quality
Beneish M -2.24, OCF/NI 0.99x in 2025, accruals 3.9% of assets - no manipulation flags in the current-year checks.
Concerns 3
m62
Persistent share count creep
Diluted shares grew from 8.9M to 12.3M (+38% over four years, 8.5% CAGR) with zero buyback offset - a meaningful per-share value leak even though SBC is only 0.7% of revenue, suggesting capital raises or acquisition scrip.
m55
Weak multi-year cash conversion
Cumulative FCF over 2021-2025 is roughly -$47M despite rising GAAP net income - only 2025 turned positive at $4.0M vs $16.8M net income. Working-capital intensity or capex is absorbing the earnings.
m20
Insider sales mechanical but net-negative optics
3 sells totaling $478K in 12 months, all following option exercises - not a red flag but no offsetting open-market buying signals conviction.
This looks like a genuine mid-cycle aerospace aftermarket turnaround - the margin curve, revenue slope, and balance sheet all point the right way, and the earnings pass the mechanical integrity checks. What keeps me from calling it Strong is two things I would want resolved: the share count has quietly grown 38% in four years with no buyback discipline, and cumulative FCF is still deeply negative despite rising GAAP profits. Until cash conversion holds for a couple more years and dilution stops, this is a Solid business improving toward better, not yet a fortress compounder.
Verify before trusting this (5)
  • Source of the ~3.4M share increase since 2021 - equity raise, acquisition consideration, or option overhang
  • Working-capital build detail (inventory vs receivables) explaining the persistent gap between net income and FCF
  • Customer concentration in the MRO business (OEM vs airline vs defense mix)
  • Backlog disclosure and whether margin gains reflect pricing, mix, or one-time contract wins
  • Capex trajectory and whether 2025's $4M FCF is a sustainable run-rate or timing-driven
Valuation / Mispricing
-69
Overvalued
edge √Σ 20 · risk √Σ 106 · conf 7/10
Price $39.15 vs composite deserved ~$14 and a quality-adjusted stretch of ~$25-28 - roughly 40-65% above deserved, negative margin of safety. attractive below $22.00

The composite fair value is $13.58 and the signal-adjusted number is $14.03 versus a $39.15 print, implying roughly 64% downside if the models are right. Even granting that an EPV floor understates a genuine aftermarket turnaround (rising MRO margins, defense tailwind, sticky single-source niches), doubling the deserved value to ~$28 still leaves the stock ~40% rich. The business is Solid, not Strong - 38% share count growth in four years and cumulative negative FCF argue against paying a premium multiple, not for one.

Cheap signals 1
m20
EPV floor likely understates growth
An EPV-only anchor at $13.58 penalizes a company mid-turnaround; deserved value on normalized aftermarket earnings is plausibly closer to $20-28, which narrows but does not close the gap.
Rich / priced-in 4
m72
Composite FV 64% below price
Signal-adjusted FV $14.03 vs $39.15 implies -64% upside. Even if the EPV floor is conservative, the gap is too wide to explain away with 'quality premium' alone.
m55
Priced for perfection
At ~$505M market cap on a small-cap MRO specialist, the tape assumes aerospace aftermarket strength, margin expansion, and clean FCF all compound - a stack of heroic assumptions.
m45
Dilution not respected in the multiple
Share count up 38% in four years with cumulative negative FCF means per-share value creation has lagged narrative - the market is paying up as if the count were static.
m30
Fallen-angel narrative already reversed
The re-rating has happened; buying now is paying for the recovery thesis after it has played out, not before.
I cannot make the math work at $39. Even if I throw out the EPV floor as too punitive and mark the business up for the genuine turnaround, I still land in the mid-$20s deserved - and that is being generous. This is a good business the market has already figured out and then some; I need it in the low $20s before valuation is even a conversation, and closer to $18-20 to get excited. Fully priced to overvalued, no margin of safety, pass.
Verify before trusting this (5)
  • Segment-level MRO margin trajectory and whether recent expansion is mix or structural
  • Free cash flow conversion in the next two prints - is cumulative FCF finally turning positive
  • Any guidance on capex intensity and working capital as revenue scales
  • Share issuance / dilution commentary and whether buyback is on the table
  • Backlog composition (defense vs commercial) and customer concentration
General Sentiment
+51
Tailwind
tail √Σ 110 · head √Σ 54 · conf 7/10

The dominant force on TAT right now is narrative, not macro. A strong 'essential supplier to the aerospace super-cycle' story is running hot - intensity strong, cult medium - and it is doing the heavy lifting to hold the stock at $39 versus a fundamentals-implied $14. The May backlog-to-$580M print gave the story fresh fuel (a 21% single-day pop is a tell that momentum money is engaged), and the 25% CAGR tape confirms buyers keep showing up on dips. That is a real tailwind on THIS name because it is a small, retail-friendly aerospace story stock where narrative dominates price discovery. The macro tape is a mild net positive but largely a non-event here: regime is neutral-to-slightly-risk-on, VIX 16, S&P barely off highs, and TAT's beta near 1 means it neither gets amplified rescue nor punishment from the tape. The rate backdrop (10y 4.68%, market PE 26.9) is a background headwind for expensive story stocks, and TAT trades on sentiment multiples, so any risk-off flinch would hit it harder than its beta implies. Durability is the soft spot: the narrative is explicitly tagged fragile, and recent 17% trailing vs 25% long-term momentum shows the second-derivative is already cooling. Net, still a tailwind, but a tiring one - the kind that stays up as long as backlog headlines keep landing and cracks the moment one quarter disappoints.

Tailwinds 4
m72
Aerospace super-cycle narrative doing the work
Strong-intensity 'essential supplier, defense + commercial recovery' story is holding the stock roughly 2.8x above DCF fair value. On a small-cap story name, that is the dominant pressure right now.
m60
Backlog beat reset the tape
The May Q1 print (EPS beat 40%, backlog ~$580M) gave bulls a hard datapoint to point at and triggered a 21% move; that kind of confirmation extends narrative durability by at least a quarter.
m55
Momentum cohort ownership
25% CAGR and cult-medium status means momentum and retail flows are structurally long here; in a neutral tape they keep bidding dips regardless of valuation.
m20
Macro tape mildly supportive, beta neutral
Neutral-to-risk-on regime with VIX 16 and beta ~1 means the tape is a light push, not a shove. Helps hold the bid, does not create it.
Headwinds 2
m45
Narrative tagged fragile, momentum cooling
Recent 17% trailing vs 25% long-term is a negative second-derivative, and durability is explicitly fragile. One soft backlog or margin quarter and the fallen-angel archetype re-asserts fast.
m30
Rates and multiple backdrop unfriendly to story stocks
10y at 4.68% and market PE 26.9 quietly pressure names trading on sentiment premiums. Not acute today, but it caps how far the narrative can stretch from the $14 fundamental anchor.
Net tailwind, but a tiring one. The aerospace super-cycle narrative is genuinely carrying this stock 2-3x above where the numbers say it should sit, and while the story is intact it is the dominant force on the tape - I have to grade that as pressure UP. But the tell-tales are lining up for a turn: durability is fragile, momentum is decelerating, and the name lives or dies on quarterly backlog confirmation. In a neutral market with rates still restrictive, I lean tailwind now and would be watching for the first crack, because when fallen-angel stories reverse, they reverse violently on names like this.
Verify before trusting this (4)
  • Next earnings print - any backlog stall or margin miss would crack the fragile narrative fast
  • Whether analyst target revisions confirm or lag the aerospace super-cycle story
  • VIX moving above 20 or a sharper S&P pullback - would disproportionately hit sentiment-premium names like this
  • Signs of the momentum cohort rotating out of small-cap aerospace into another theme
The market-wide tape + this name's exposure to it (beta / sector / narrative durability). Context on the non-fundamental pressure — not a call on the business or the price. processId: detail-general-sentiment
Growth Outlook
not run

This lens hasn't been run for this ticker yet.

The forward growth verdict — is the business itself likely to grow (next 2 quarters / year 1 / years 2–3), judged against its category and against printed expectations. The full horizon ladder + creme renders on the Growth Outlook card above. Not a call on the price (Valuation owns that) or the tape (Sentiment owns that).
Please log in to view trade setups
The Augustus trade-setup read is a members feature.
Log in
Lenses kept deliberately separate — Company Quality (price-agnostic), Valuation (price-conditional), General Sentiment (non-fundamental macro/narrative pressure), and Growth Outlook (the forward growth verdict). The scores are not blended. Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Price Prediction
Lower -19.6% v0.6.0 View full prediction →

When we made this prediction on Aug 5, 2026, TATT was $41.65. We expect it to be $33.50 by Feb 2027, and we consider it great value under $22.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 5, 2026.

Price when predicted$41.65
Our estimate for Feb 2027$33.50-19.6%
Great value below$22.00
Price history shown (6 Months)

Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.

Community AI Feedback
No community reviews yet for TATT. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
v1.1.562 · 9b2927c4 · 2026-08-22 16:52:06